NORTH
CHICAGO, Ill., June 20,
2025 /PRNewswire/ -- The board of directors
of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash
dividend of $1.64 per
share.
The cash dividend is payable August 15,
2025, to stockholders of record at the close of business on
July 15, 2025.
Since the company's inception in 2013, AbbVie has increased its
dividend by 310 percent. AbbVie is a member of the S&P Dividend
Aristocrats Index, which tracks companies that have annually
increased their dividend for at least 25 consecutive years.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines
and solutions that solve serious health issues today and address
the medical challenges of tomorrow. We strive to have a remarkable
impact on people's lives across several key therapeutic areas
including immunology, oncology, neuroscience and eye care – and
products and services in our Allergan Aesthetics portfolio. For
more information about AbbVie, please visit us at www.abbvie.com.
Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly
Twitter) and YouTube.
|
Media:
|
Investors:
|
|
Gabby
Tarbert
|
Liz Shea
|
|
(224)
244-0111
|
(847)
935-2211
|
|
gabrielle.tarbert@abbvie.com
|
liz.shea@abbvie.com
|
View original
content:https://www.prnewswire.com/news-releases/abbvie-declares-quarterly-dividend-302486685.html
SOURCE AbbVie